Detalhe da pesquisa
1.
Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study.
Ther Adv Med Oncol
; 14: 17588359221141760, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601632